@misc{item_3288755,
  title = {{A Methodological Checklist for fMRI Drug Cue Reactivity Studies: Development and Expert Consensus}},
  abstract = {{Background Cue reactivity is one of the most frequently used paradigms in functional magnetic resonance imaging (fMRI) studies of substance use disorders (SUDs). Although there have been many promising results elucidating the neurocognitive mechanisms of SUDs and SUD treatments, heterogeneities in participant characteristics, task design, craving assessment, scanning preparation and analysis decisions limit rigor and reproducibility in the field of fMRI of drug cue reactivity (FDCR), hampering clinical translation and synthesis by systematic reviews and meta-analyses. The aim of this consensus paper and Delphi study is to outline the important methodological aspects of FDCR studies and present a list of items and recommendations that should be taken into account when designing FDCR studies and reporting their results. Methods Fifty-five FDCR scientists from around the world participated. First, an initial checklist of items deemed important in FDCR studies was developed by a group of members from the ENIGMA Addiction Consortium based on a systematic review. Then, using a modified Delphi consensus method, all experts were asked to comment on, revise or add items to the initial checklist. Subsequently, experts were asked to rate the importance of the items. Results Thirty-seven items were proposed in the first round. After the commenting phase, seven new items suggested by experts were added and six were removed. The final 38 items that reached a defined consensus threshold in the rating phase were classified under seven categories and are considered important for conducting and reporting in any FDCR study. Conclusion This paper proposes a list of items and additional recommendations that researchers in the field of FDCR are encouraged to note and report when designing an FDCR study and reporting its results. Along with the presentation of a quality control checklist with Yes/No ratable items, various challenges in moving towards greater homogeneity in FDCR research and widespread use of FDCR to investigate SUDs and develop clinically relevant biomarkers are discussed.}},
  year = {2020},
  slug = {item_3288755},
  author = {Ekhtiari, H and Zare-Bidoky, M and Sangchooli, A and Janes, AC and Kaufman, MJ and Oliver, J and Prisciandaro, JJ and W\"ustenberg, T and Anton, RF and Bach, P and Baldacchino, A and Beck, A and Bjork, J and Brewer, J and Childress, AR and Claus, E and Courtney, KE and Ebrahimi, M and Filbey, FM and Ghahremani, D and Azbari, PG and Goldstein, RZ and Goudrian, A and Grodin, E and Hamilton, C and Hanlon, PA and Abharian, PH and Heinz, A and Joseph, JE and Kiefer, F and Zonoozi, AK and Kober, H and Kuplicki, R and Li, Q and London, ED and McClernon, J and Noori, HR and Owens, MM and Paulus, M and Perini, I and Potenza, M and Potvin, S and Ray, L and Schacht, JP and Seo, D and Sinha, R and Smolka, MN and Spanagel, F and Steele, VR and Stein, E and Steins Loeber, S and Tapert, SF and Verdejo-Garcia, A and Wetherill, R and Wilson, SJ and Witkiewitz, K and Yuan, K and Zhang, X and Zilverstand, A}
}